The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Dual Stem Loops within the Poliovirus Internal Ribosomal Entry Site Control Neurovirulence
Open accessAbstract
In the human central nervous system, susceptibility to poliovirus (PV) infection is largely confined to a specific subpopulation of neuronal cells. PV tropism is likely to be determined by cell-external components such as the PV receptor CD155, as well as cell-internal constraints such as the availability of a suitable microenvironment for virus propagation. We reported previously that the exchange of the cognate internal ribosomal entry site (IRES) within the 5′ nontranslated region of PV with its counterpart from human rhinovirus type 2 (HRV2) can eliminate the neuropathogenic phenotype in a transgenic mouse model for poliomyelitis without diminishing the growth properties in HeLa cells. We now show that attenuation of neurovirulence of PV/HRV2 chimeras is not confined to CD155 transgenic mice but is evident also after intraspinal inoculation into Cynomolgus monkeys. We have dissected the PV and HRV2 IRES elements to determine those structures responsible for neurovirulence (or attenuation) of these chimeric viruses. We report that two adjacent stem loop structures within the IRES cooperatively determine neuropathogenicity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The substitutions in the IRES, which alter stem-loop structures (63, 68, 126, 132) and reduce the efficiency of initiation of translation of the poliovirus RNA template (68, 188), contribute most to the attenuated phenotype of the Sabin 1 and Sabin 3 strains.”
From VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION (2005) · cites this paper as [63]
Citations
Cites
Pathology of Tumours of the Nervous System
(1990) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199001000-00011 · Cited by 3,581
Pelletier, J., & Sonenberg, N. (1988) · Nature · doi:10.1038/334320a0 · Cited by 1,953
Jang, S. K., Kräusslich, H., Nicklin, M. J. H., Duke, G. M., Palmenberg, A. C., & Wimmer, E. (1988) · Journal of Virology · doi:10.1128/jvi.62.8.2636-2643.1988 · Cited by 1,390
Self-citationInternal ribosome entry site within hepatitis C virus RNA
Tsukiyama–Kohara, K., Iizuka, N., Kohara, M., & Nomoto, A. (1992) · Journal of Virology · doi:10.1128/jvi.66.3.1476-1483.1992 · Cited by 925
Self-citationPrimary structure, gene organization and polypeptide expression of poliovirus RNA
Kitamura, N., Semler, B. L., Rothberg, P. G., Larsen, G. R., Adler, C. J., Dorner, A. J., Emini, E. A., Hanecak, R., Lee, J. J., van der Werf, S., et al. (1981) · Nature · doi:10.1038/291547a0 · Cited by 914
Self-citationWimmer, E., Hellen, C. U. T., & Cao, X. (1993) · Annual Review of Genetics · doi:10.1146/annurev.ge.27.120193.002033 · Cited by 554
Self-citationEvans, D. M. A., Dunn, G., Minor, P. D., Schild, G. C., Cann, A. J., Stanway, G., Almond, J. W., Currey, K., & Maizel, J. V. (1985) · Nature · doi:10.1038/314548a0 · Cited by 440
Jang, S. K., Davies, M. V., Kaufman, R. J., & Wimmer, E. (1989) · Journal of Virology · doi:10.1128/jvi.63.4.1651-1660.1989 · Cited by 413
Self-citationPATHOLOGY OF THE NERVOUS SYSTEM
(1949) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1949.tb37099.x · Cited by 405
Internal initiation of translation in eukaryotes: the picornavirus paradigm and beyond.
Jackson, R. J., & Kaminski, A. (1995) · PubMed · Cited by 346
Research works printed but not linked: 1
- World Health Organization Requirements for poliomyelitis vaccine (oral). WHO expert committee on biological standardization. Annex 4.Tech. Rep. Ser. 687 1983 130 133
Cited by
Sorted by citations
VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION
Kew, O. M., Sutter, R. W., de Gourville, E. M., Dowdle, W. R., & Pallansch, M. A. (2005) · Annual Review of Microbiology · doi:10.1146/annurev.micro.58.030603.123625 · Cited by 703
An overview of the evolution of enterovirus 71 and its clinical and public health significance
McMinn, P. C. (2002) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2002.tb00601.x · Cited by 700
Kew, O., Morris-Glasgow, V., Landaverde, M., Burns, C., Shaw, J., Garib, Z., André, J., Blackman, E., Freeman, C. J., Jorba, J., et al. (2002) · Science · doi:10.1126/science.1068284 · Cited by 600
Intergeneric poliovirus recombinants for the treatment of malignant glioma
Gromeier, M., Lachmann, S., Rosenfeld, M. R., Gutin, P. H., & Wimmer, E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.12.6803 · Cited by 363
Self-citationTranslational Control of Viral Gene Expression in Eukaryotes
Gale, M., Tan, S., & Katze, M. G. (2000) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.64.2.239-280.2000 · Cited by 316
Cellular receptors for viruses: links to tropism and pathogenesis
Schneider‐Schaulies, J. (2000) · Journal of General Virology · doi:10.1099/0022-1317-81-6-1413 · Cited by 229
Epigenetics in the Nervous System: Figure 1.
Jiang, Y., Langley, B. C., Lubin, F. D., Renthal, W. R., Wood, M. A., Yasui, D. H., Kumar, A., Nestler, E. J., Akbarian, S., & Beckel-Mitchener, A. C. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.3797-08.2008 · Cited by 216
Enterovirus infections of the central nervous system
Rhoades, R. E., Tabor-Godwin, J. M., Tsueng, G., & Feuer, R. (2011) · Virology · doi:10.1016/j.virol.2010.12.014 · Cited by 213
Internal ribosome entry site biology and its use in expression vectors
Martı́nez-Salas, E. (1999) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(99)00010-5 · Cited by 193
Targeting PVR (CD155) and its receptors in anti-tumor therapy
Brlić, P. K., Roviš, T. L., Cinamon, G., Tsukerman, P., Mandelboim, O., & Jonjić, S. (2018) · Cellular and Molecular Immunology · doi:10.1038/s41423-018-0168-y · Cited by 172
Sutter, R. W., Kew, O. M., & Cochi, S. L. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-3611-1.50030-1 · Cited by 167
Direct functional interaction of initiation factor eIF4G with type 1 internal ribosomal entry sites
de Breyne, S., Yu, Y., Unbehaun, A., Pestova, T. V., & Hellen, C. U. T. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900153106 · Cited by 162
Virus-Based Immunotherapy of Glioblastoma
Martikainen, M., & Essand, M. (2019) · Cancers · doi:10.3390/cancers11020186 · Cited by 144
Brain-Derived Neurotrophic Factor in Amygdala-Dependent Learning
Rattiner, L. M., Davis, M. E., & Ressler, K. J. (2005) · The Neuroscientist · doi:10.1177/1073858404272255 · Cited by 141
Oncolytic viruses: From bench to bedside with a focus on safety
Buijs, P., Verhagen-Oldenampsen, J., van Eijck, C. H. J., & van den Hoogen, B. G. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1037058 · Cited by 139
Rattiner, L. M., Davis, M. E., & Ressler, K. J. (2004) · Learning & Memory · doi:10.1101/lm.83304 · Cited by 143
Poliovirus receptor CD155-targeted oncolysis of glioma
Merrill, M. K., Bernhardt, G., Sampson, J. H., Wikstrand, C. J., Bigner, D. D., & Gromeier, M. (2004) · Neuro-Oncology · doi:10.1215/s1152851703000577 · Cited by 135
Self-citationOncolytic biotherapy: a novel therapeutic platform
Hawkins, L. K., Lemoine, N. R., & Kirn, D. H. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(01)00618-0 · Cited by 131
Arita, M., Nagata, N., Iwata, N., Ami, Y., Suzaki, Y., Mizuta, K., Iwasaki, T., Sata, T., Wakita, T., & Shimizu, H. (2007) · Journal of Virology · doi:10.1128/jvi.02856-06 · Cited by 129
Self-citationRecent Developments in Glioblastoma Therapy: Oncolytic Viruses and Emerging Future Strategies
Hamad, A., Yusubalieva, G. M., Baklaushev, V. P., Chumakov, P. M., & Lipatova, A. V. (2023) · Viruses · doi:10.3390/v15020547 · Cited by 124
Oncolytic Viruses: Clinical Applications as Vectors for the Treatment of Malignant Gliomas
Shah, A. C., Benos, D. J., Gillespie, G. Y., & Markert, J. M. (2003) · Journal of Neuro-Oncology · doi:10.1023/b:neon.0000003651.97832.6c · Cited by 116
Paradoxes of the replication of picornaviral genomes
Agol, V. I., Paul, A. V., & Wimmer, E. (1999) · Virus Research · doi:10.1016/s0168-1702(99)00037-4 · Cited by 112
Self-citationMerrill, M. K., & Gromeier, M. (2006) · Journal of Virology · doi:10.1128/jvi.00243-06 · Cited by 107
Self-citationStopping poliovirus vaccination after eradication: issues and challenges.
Wood, D. J., Sutter, R. W., & Dowdle, W. R. (2000) · Europe PMC (PubMed Central) · doi:10.1590/s0042-96862000000300010 · Cited by 107
Dunn, J. J., Chapman, N. M., Tracy, S., & Romero, J. (2000) · Journal of Virology · doi:10.1128/jvi.74.10.4787-4794.2000 · Cited by 106
Epidemics to eradication: the modern history of poliomyelitis
Jesus, N. H. D. (2007) · Virology Journal · doi:10.1186/1743-422x-4-70 · Cited by 104
Bergthaler, A., Flatz, L., Hegazy, A. N., Johnson, S., Horváth, E. J., Löhning, M., & Pinschewer, D. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011998107 · Cited by 102
Enterovirus/Picornavirus infections
Jubelt, B., & Lipton, H. L. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53488-0.00018-3 · Cited by 105
Immunotherapy approaches in the treatment of malignant brain tumors
Dunn‐Pirio, A., & Vlahovic, G. (2016) · Cancer · doi:10.1002/cncr.30371 · Cited by 91
Macadam, A. J., Ferguson, G., Stone, D. M., Meredith, J., Knowlson, S., Auda, G., Almond, J. W., & Minor, P. D. (2006) · Journal of Virology · doi:10.1128/jvi.00370-06 · Cited by 89
Dobrikova, E. Y., Broadt, T. L., Poiley-Nelson, J., Yang, X., Soman, G., Giardina, S. L., Harris, R., & Gromeier, M. (2008) · Molecular Therapy · doi:10.1038/mt.2008.184 · Cited by 85
Self-citationDendritic Cells and Macrophages Are Productively Infected by Poliovirus
Wahid, R., Cannon, M. J., & Chow, M. (2004) · Journal of Virology · doi:10.1128/jvi.79.1.401-409.2005 · Cited by 85
Oncolytic polio virotherapy of cancer
Brown, M. C., Dobrikova, E. Y., Dobrikov, M. I., Walton, R. W., Gemberling, S. L., Nair, S. K., Desjardins, A., Sampson, J. H., Friedman, H. S., Friedman, A. H., et al. (2014) · Cancer · doi:10.1002/cncr.28862 · Cited by 82
Self-citationOncolytic Viral Therapy of Malignant Glioma
Parker, J. N., Bauer, D. F., Cody, J. J., & Markert, J. M. (2009) · Neurotherapeutics · doi:10.1016/j.nurt.2009.04.011 · Cited by 82
The structure–function relationship of the enterovirus 3′-UTR
Zoll, J., Heus, H. A., van Kuppeveld, F. J. M., & Melchers, W. J. G. (2008) · Virus Research · doi:10.1016/j.virusres.2008.07.014 · Cited by 82
Yeh, M. T., Wang, S.-W., Yu, C., Lin, K.-H., Lei, H.-Y., Su, I. J., & Wang, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027082 · Cited by 81
Muslin, C., Joffret, M., Pelletier, I., Blondel, B., & Delpeyroux, F. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005266 · Cited by 81
Genetics, Pathogenesis and Evolution of Picornaviruses
Gromeier, M., Wimmer, E., & Gorbalenya, A. E. (1999) · Elsevier eBooks · doi:10.1016/b978-012220360-2/50013-1 · Cited by 81
Self-citationCrotty, S., Lohman, B. L., Lü, F. X.-S., Tang, S., Miller, C. J., & Andino, R. (1999) · Journal of Virology · doi:10.1128/jvi.73.11.9485-9495.1999 · Cited by 80
Impaired Binding of Standard Initiation Factors Mediates Poliovirus Translation Attenuation
Ochs, K., Zeller, A., Saleh, L., Bassili, G., Song, Y., Sonntag, A., & Niepmann, M. (2002) · Journal of Virology · doi:10.1128/jvi.77.1.115-122.2003 · Cited by 79
Merrill, M. K., Dobrikova, E. Y., & Gromeier, M. (2006) · Journal of Virology · doi:10.1128/jvi.80.7.3147-3156.2006 · Cited by 79
Self-citationAsymptomatic circulation of HEV71 in Norway
Witsø, E., Palacios, G. F., Rønningen, K. S., Cinek, O., Janowitz, D., Rewers, M., Grinde, B., & Lipkin, W. I. (2006) · Virus Research · doi:10.1016/j.virusres.2006.07.015 · Cited by 76
Guo, H., Li, Y., Liu, G., Jiang, Y., Shen, S., Bi, R., Huang, H., Cheng, T., Wang, C., & Wei, W. (2019) · Nature Communications · doi:10.1038/s41467-019-12040-9 · Cited by 74
Toyoda, H., Yin, J., Mueller, S., Wimmer, E., & Cello, J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3713 · Cited by 72
Self-citationEnhanced antiglioma activity of chimeric HCMV/HSV-1 oncolytic viruses
Shah, A. C., Parker, J. N., Gillespie, G. Y., Lakeman, F. D., Meleth, S., Markert, J. M., & Cassady, K. A. (2007) · Gene Therapy · doi:10.1038/sj.gt.3302942 · Cited by 68
Dunn, J. J., Bradrick, S. S., Chapman, N. M., Tracy, S., & Romero, J. R. (2003) · The Journal of Infectious Diseases · doi:10.1086/374877 · Cited by 66
Ochiai, H., Campbell, S. A., Archer, G. E., Chewning, T. A., Dragunsky, E. M., Ap, I., Gromeier, M., & Sampson, J. H. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1595 · Cited by 64
Self-citationGoetz, C., & Gromeier, M. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.02.005 · Cited by 61
Self-citationGene therapy for malignant glioma
Okura, H., Smith, C. A., & Rutka, J. T. (2014) · Molecular and Cellular Therapies · doi:10.1186/2052-8426-2-21 · Cited by 60
Dobrikova, E. Y., Florez, P., Bradrick, S. S., & Gromeier, M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2436464100 · Cited by 56
Self-citationDobrikova, E. Y., Goetz, C., Walters, R. W., Lawson, S. K., Peggins, J. O., Muszynski, K. W., Ruppel, S., Poole, K., Giardina, S. L., Vela, E. M., et al. (2011) · Journal of Virology · doi:10.1128/jvi.06427-11 · Cited by 55
Self-citationDeJesus, N., Franco, D., Paul, A. V., Wimmer, E., & Cello, J. (2005) · Journal of Virology · doi:10.1128/jvi.79.22.14235-14243.2005 · Cited by 55
Self-citationOncolytic Poliovirus Against Malignant Glioma
Goetz, C., Dobrikova, E. Y., Shveygert, M., Dobrikov, M. I., & Gromeier, M. (2011) · Future Virology · doi:10.2217/fvl.11.76 · Cited by 53
Self-citationThe success (or not) of HUGO nomenclature
Tamames (2006) · Genome biology · doi:10.1186/gb-2006-7-5-402 · Cited by 52
Ochiai, H., Moore, S. A., Archer, G. E., Okamura, T., Chewning, T. A., Marks, J. R., Sampson, J. H., & Gromeier, M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0694 · Cited by 52
Self-citationPathogenicity and virulence of hepatitis A virus
Pintó, R. M., Rodríguez, F., Costafreda, M. I., Chavarria-Miró, G., Guix, S., Ribes, E., & Bosch, A. (2021) · Virulence · doi:10.1080/21505594.2021.1910442 · Cited by 50
Interaction of Translation Initiation Factor eIF4B with the Poliovirus Internal Ribosome Entry Site
Ochs, K., Saleh, L., Bassili, G., Sonntag, V. H., Zeller, A., & Niepmann, M. (2002) · Journal of Virology · doi:10.1128/jvi.76.5.2113-2122.2002 · Cited by 50
Genetic Determinants of Cell Type-Specific Poliovirus Propagation in HEK 293 Cells
Campbell, S. A., Lin, J., Dobrikova, E. Y., & Gromeier, M. (2005) · Journal of Virology · doi:10.1128/jvi.79.10.6281-6290.2005 · Cited by 50
Self-citationLin, P., Lee, J., Liao, M., Hsu, H., Chiu, S.-J., Liu, H., & Shih, W. (2009) · Virology · doi:10.1016/j.virol.2008.12.028 · Cited by 48
Translation initiation of viral mRNAs
López‐Lastra, M., Ramdohr, P., Letelier, A., Vallejos, M., Vera‐Otarola, J., & Valiente‐Echeverría, F. (2010) · Reviews in Medical Virology · doi:10.1002/rmv.649 · Cited by 49
Molecular strategies for the treatment of malignant glioma—genes, viruses, and vaccines
Selznick, L. A., Shamji, M. F., Fecci, P. E., Gromeier, M., Friedman, A. H., & Sampson, J. H. (2008) · Neurosurgical Review · doi:10.1007/s10143-008-0121-0 · Cited by 47
Self-citationBrown, M. C., Bryant, J. D., Dobrikova, E. Y., Shveygert, M., Bradrick, S. S., Chandramohan, V., Bigner, D. D., & Gromeier, M. (2014) · Journal of Virology · doi:10.1128/jvi.01883-14 · Cited by 45
Self-citationDissemination of Internal Ribosomal Entry Sites (IRES) Between Viruses by Horizontal Gene Transfer
Arhab, Y., Bulakhov, A. G., Pestova, T. V., & Hellen, C. U. T. (2020) · Viruses · doi:10.3390/v12060612 · Cited by 45
Recent insights into poliovirus pathogenesis
Ohka, S., & Nomoto, A. (2001) · Trends in Microbiology · doi:10.1016/s0966-842x(01)02200-4 · Cited by 44
Self-citationMapping of tissue tropism determinants in coxsackievirus genomes
Harvala, H., Kalimo, H., Dahllund, L., Santti, J., Hughes, P., Hyypiä, T., & Stanway, G. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-7-1697 · Cited by 43
Leon, L. A. A., Marchevsky, R. S., de Paula, V. S., Hooper, C., Freire, M. D. S., Gaspar, A. M. C., & Pinto, M. A. (2009) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2009.00699.x · Cited by 37
Ehrenfeld, E., & Teterina, N. L. (2014) · ASM Press eBooks · doi:10.1128/9781555817916.ch14 · Cited by 36
Yanagiya, A., Ohka, S., Hashida, N., Okamura, M., Taya, C., Kamoshita, N., Iwasaki, K., Sasaki, Y., Yonekawa, H., & Nomoto, A. (2003) · Journal of Virology · doi:10.1128/jvi.77.19.10479-10487.2003 · Cited by 35
Self-citationCurrent landscape and perspective of oncolytic viruses and their combination therapies
Su, Y., Su, C., & Qin, L. (2022) · Translational Oncology · doi:10.1016/j.tranon.2022.101530 · Cited by 34
Tissue tropism of recombinant coxsackieviruses in an adult mouse model
Harvala, H., Kalimo, H., Bergelson, J. M., Stanway, G., & Hyypiä, T. (2005) · Journal of General Virology · doi:10.1099/vir.0.80603-0 · Cited by 34
Translation initiation of the HIV-1 mRNA
Ohlmann, T., Mengardi, C., & López‐Lastra, M. (2014) · Translation · doi:10.4161/2169074x.2014.960242 · Cited by 36
Oncolytic viruses as therapeutic agents
Wildner, O. (2001) · Annals of Medicine · doi:10.3109/07853890109002081 · Cited by 33
RNA-Binding Proteins as Regulators of Internal Initiation of Viral mRNA Translation
López‐Ulloa, B., Fuentes, Y., Pizarro-Ortega, M. S., & López‐Lastra, M. (2022) · Viruses · doi:10.3390/v14020188 · Cited by 33
Yang, D., Cheung, P., Sun, Y., Ji, Y., Zhang, H., Carthy, C. M., Anderson, D. R., Bohunek, L., Wilson, J. E., & McManus, B. M. (2002) · Virology · doi:10.1006/viro.2002.1770 · Cited by 31
Formulation technologies for oral vaccines
New, R. R. C. (2019) · Clinical & Experimental Immunology · doi:10.1111/cei.13352 · Cited by 31
Oncolytic Viruses as a Platform for the Treatment of Malignant Brain Tumors
de Sostoa, J., Dutoit, V., & Migliorini, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207449 · Cited by 30
Cello, J., Toyoda, H., DeJesus, N., Dobrikova, E. Y., Gromeier, M., & Wimmer, E. (2007) · Journal of Medical Virology · doi:10.1002/jmv.21063 · Cited by 29
Self-citationYang, X., Chen, E., Jiang, H., Muszynski, K. W., Harris, R. D., Giardina, S. L., Gromeier, M., Mitra, G., & Soman, G. (2008) · Journal of Virological Methods · doi:10.1016/j.jviromet.2008.09.020 · Cited by 29
Self-citationShah, S. (2023) · Medical Sciences · doi:10.3390/medsci12010001 · Cited by 28
Bradrick, S. S., Lieben, E. A., Carden, B. M., & Romero, J. R. (2001) · Journal of Virology · doi:10.1128/jvi.75.14.6472-6481.2001 · Cited by 27
Zhao, W. D., Lahser, F. C., & Wimmer, E. (2000) · Journal of Virology · doi:10.1128/jvi.74.13.6223-6226.2000 · Cited by 27
Self-citationRole of Cellular Structures in Viral RNA Replication
Egger, D., Gosert, R., & Bienz, K. (2014) · ASM Press eBooks · doi:10.1128/9781555817916.ch20 · Cited by 27
Yang, Y., Brown, M. C., Zhang, G., Stevenson, K., Mohme, M., Kornahrens, R., Bigner, D. D., Ashley, D. M., Lopez, G. Y., & Gromeier, M. (2023) · Neuro-Oncology · doi:10.1093/neuonc/noad052 · Cited by 28
Self-citationZhang, Y., Yan, D., Zhu, S., Nishimura, Y., Ye, X., Wang, D., Jorba, J. C., Zhu, H., An, H., Shimizu, H., et al. (2015) · Scientific Reports · doi:10.1038/srep17291 · Cited by 25
Melchers, W. J. G., Bakkers, J. M. J. E., Slot, H. J. B., Galama, J. M. D., Agol, V. I., & Pilipenko, E. V. (2000) · RNA · doi:10.1017/s1355838200000480 · Cited by 25
Martinez, C. V., Old, M. O., Kwock, D., Khan, S. S., García, J. J., Chan, C. S., Webster, R. L., Halpern, M. S., & Maldonado, Y. (2004) · The Journal of Infectious Diseases · doi:10.1086/421703 · Cited by 23
Biomarkers in Japanese Encephalitis: A Review
Upadhyay, R. K. (2013) · BioMed Research International · doi:10.1155/2013/591290 · Cited by 23
Sutter, R. W., Kew, O. M., Cochi, S. L., & Aylward, R. B. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35761-6.00048-1 · Cited by 22
Immunodeficiency-associated Vaccine-Derived Poliovirus Type 3 in Infant, South Africa, 2011
Gumede, N., Muthambi, V., & Schoub, B. D. (2012) · Emerging infectious diseases · doi:10.3201/eid1806.120037 · Cited by 21
Determinants of Poliovirus Pathogenesis
Gromeier, M., & Nomoto, A. (2014) · Molecular Biology of Picornavirus · doi:10.1128/9781555817916.ch29 · Cited by 20
Self-citationJahan, N., Wimmer, E., & Mueller, S. (2011) · Journal of Virology · doi:10.1128/jvi.01804-09 · Cited by 19
Self-citationPicornaviruses and RNA Metabolism: Local and Global Effects of Infection
Holmes, A. C., & Semler, B. L. (2019) · Journal of Virology · doi:10.1128/jvi.02088-17 · Cited by 19
de Sessions, P. F., Dobrikova, E. Y., & Gromeier, M. (2007) · Journal of Virology · doi:10.1128/jvi.00321-07 · Cited by 19
Self-citationTherapeutic Use of Native and Recombinant Enteroviruses
Ylä-Pelto, J., Tripathi, L., & Susi, P. (2016) · Viruses · doi:10.3390/v8030057 · Cited by 18
Jahan, N., Wimmer, E., & Mueller, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060791 · Cited by 18
Self-citationPicornavirus Genetics: an Overview
Agol, V. I. (2014) · ASM Press eBooks · doi:10.1128/9781555817916.ch22 · Cited by 18
Poliovirus proves IRES-istible in vivo
Semler, B. L. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22139 · Cited by 17
Dobrikova, E. Y., Florez, P., & Gromeier, M. (2003) · Virology · doi:10.1016/s0042-6822(03)00191-0 · Cited by 16
Self-citationAgainst the Resilience of High-Grade Gliomas: Gene Therapies (Part II)
Lucifero, A. G., & Luzzi, S. (2021) · Brain Sciences · doi:10.3390/brainsci11080976 · Cited by 15
Dobrikov, M. I., Dobrikova, E. Y., McKay, Z. P., Kastan, J. P., Brown, M. C., & Gromeier, M. (2022) · mBio · doi:10.1128/mbio.00854-22 · Cited by 14
Self-citation
Metadata
- Authors
- Gromeier, M., Bossert, B., Arita, M., Nomoto, A., & Wimmer, E.
- Affiliations
- State University of New York (US)
- Institute of Medical Science, The University of Tokyo (JP)
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 1999-02
- Volume
- 73
- Issue
- 2
- Pages
- 958-964
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- PMC
- PMC103915
- OpenAlex
- W1529709430
- Cited by
- 160
- References
- 45
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 1 · 2023: 8 · 2022: 5 · 2021: 4 · 2020: 4 · 2019: 5 · 2018: 2 · 2017: 1 · 2016: 6 · 2015: 4 · 2014: 14 · 2013: 5 · 2012: 4
- FWCI
- 7.48
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Virology (publishedVersion)
- PubMed Central (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (R01AI032100, R01AI039485)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Keywords
- poliovirus, internal ribosome entry site, neurovirulence, stem-loop structure, CD155, 5' untranslated region, neurotropism, viral attenuation, transgenic mouse model, Macaca fascicularis
- MeSH terms
- Animals, Base Sequence, HeLa Cells, Humans, Macaca fascicularis, Membrane Proteins, Mice, Transgenic, Molecular Sequence Data, Neurons, Nucleic Acid Conformation, Receptors, Virus, RNA, Viral, Virulence, Poliovirus, 5' Untranslated Regions, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review